These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 19642586)

  • 21. Decreased aortic smooth muscle contraction in a rat model of multibacterial sepsis.
    Wang C; Mansard A; Giummelly P; Atkinson J
    Fundam Clin Pharmacol; 2004 Dec; 18(6):679-83. PubMed ID: 15548239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
    Garthwaite J; Southam E; Boulton CL; Nielsen EB; Schmidt K; Mayer B
    Mol Pharmacol; 1995 Aug; 48(2):184-8. PubMed ID: 7544433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal interstitial guanosine cyclic 3', 5'-monophosphate mediates pressure-natriuresis via protein kinase G.
    Jin XH; McGrath HE; Gildea JJ; Siragy HM; Felder RA; Carey RM
    Hypertension; 2004 May; 43(5):1133-9. PubMed ID: 15007031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery.
    Brunner F; Schmidt K; Nielsen EB; Mayer B
    J Pharmacol Exp Ther; 1996 Apr; 277(1):48-53. PubMed ID: 8613957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes.
    Wegener JW; Closs EI; Förstermann U; Nawrath H
    Br J Pharmacol; 1999 Jun; 127(3):693-700. PubMed ID: 10401560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual actions of dephostatin on the nitric oxide/cGMP-signalling pathway in porcine iliac arteries.
    Persson AA; Gunnarsson P; Lindström E; Grenegård M
    Eur J Pharmacol; 2005 Oct; 521(1-3):124-32. PubMed ID: 16182278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
    Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diethyl-4,4'-dihydroxy-8,3'-neolign-7,7'-dien-9,9'-dionate exhibits antihypertensive activity in rats through increase in intracellular cGMP level and blockade of calcium channels.
    Singh A; Kumar BS; Alam S; Iqbal H; Shafiq M; Khan F; Negi AS; Hanif K; Chanda D
    Eur J Pharmacol; 2017 Mar; 799():84-93. PubMed ID: 28159537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine]-induced dilation in ovine pulmonary artery: role of sodium pump.
    Bawankule DU; Sathishkumar K; Sardar KK; Chanda D; Krishna AV; Prakash VR; Mishra SK
    J Pharmacol Exp Ther; 2005 Jul; 314(1):207-13. PubMed ID: 15792996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relaxation to authentic nitric oxide and SIN-1 in rat isolated mesenteric arteries: variable role for smooth muscle hyperpolarization.
    Plane F; Sampson LJ; Smith JJ; Garland CJ
    Br J Pharmacol; 2001 Jul; 133(5):665-72. PubMed ID: 11429390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate.
    Hussain AS; Marks GS; Brien JF; Nakatsu K
    Can J Physiol Pharmacol; 1997 Aug; 75(8):1034-7. PubMed ID: 9360020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
    Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
    Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of soluble guanylate cyclase alpha(1) and alpha(2), and SK(Ca) channels in NANC relaxation of mouse distal colon.
    Dhaese I; Vanneste G; Sips P; Buys E; Brouckaert P; Lefebvre RA
    Eur J Pharmacol; 2008 Jul; 589(1-3):251-9. PubMed ID: 18572161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G; Burnett JC
    Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 1 diabetes and hypercholesterolaemia reveal the contribution of endothelium-derived hyperpolarizing factor to endothelium-dependent relaxation of the rat aorta.
    Malakul W; Thirawarapan S; Suvitayavat W; Woodman OL
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):192-200. PubMed ID: 17941894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of soluble guanylyl cyclase by BAY 41-2272 relaxes anococcygeus muscle: interaction with nitric oxide.
    Teixeira CE; Priviero FB; Claudino MA; Baracat JS; De Nucci G; Webb RC; Antunes E
    Eur J Pharmacol; 2006 Jan; 530(1-2):157-65. PubMed ID: 16371226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternative splicing of cGMP-dependent protein kinase I in angiotensin-hypertension: novel mechanism for nitrate tolerance in vascular smooth muscle.
    Gerzanich V; Ivanov A; Ivanova S; Yang JB; Zhou H; Dong Y; Simard JM
    Circ Res; 2003 Oct; 93(9):805-12. PubMed ID: 14512447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive Effects of a Soluble Guanylate Cyclase Stimulator.
    Bykov VV; Birulina YG; Nosarev AV; Vengerovskii AI; Udut VV
    Bull Exp Biol Med; 2022 Nov; 174(1):33-36. PubMed ID: 36437315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasorelaxing effects of propranolol in rat aorta and mesenteric artery: a role for nitric oxide and calcium entry blockade.
    Priviero FB; Teixeira CE; Toque HA; Claudino MA; Webb RC; De Nucci G; Zanesco A; Antunes E
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):448-55. PubMed ID: 16700877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelium-derived nitric oxide inhibits the relaxation of the porcine coronary artery to natriuretic peptides by desensitizing big conductance calcium-activated potassium channels of vascular smooth muscle.
    Liang CF; Au AL; Leung SW; Ng KF; Félétou M; Kwan YW; Man RY; Vanhoutte PM
    J Pharmacol Exp Ther; 2010 Jul; 334(1):223-31. PubMed ID: 20332186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.